ADRx Pharmaceuticals closes full over-allotment option in IPO
ADRx Pharmaceuticals said underwriters fully exercised their option to purchase additional shares in its initial public offering.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.